CN1151154C - Preparation process of oxysophocarpine - Google Patents

Preparation process of oxysophocarpine Download PDF

Info

Publication number
CN1151154C
CN1151154C CNB001333518A CN00133351A CN1151154C CN 1151154 C CN1151154 C CN 1151154C CN B001333518 A CNB001333518 A CN B001333518A CN 00133351 A CN00133351 A CN 00133351A CN 1151154 C CN1151154 C CN 1151154C
Authority
CN
China
Prior art keywords
sophocarpine
preparation technology
sophocarpidin
extraction
reaction solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB001333518A
Other languages
Chinese (zh)
Other versions
CN1354181A (en
Inventor
王忠效
高斌
黄建军
王端宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NINGXIA INST OF MEDICAMENT (CO LTD)
Original Assignee
NINGXIA INST OF MEDICAMENT (CO LTD)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NINGXIA INST OF MEDICAMENT (CO LTD) filed Critical NINGXIA INST OF MEDICAMENT (CO LTD)
Priority to CNB001333518A priority Critical patent/CN1151154C/en
Publication of CN1354181A publication Critical patent/CN1354181A/en
Application granted granted Critical
Publication of CN1151154C publication Critical patent/CN1151154C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention provides a technology for preparing oxysophocarpine. Firstly, sophocarpine is added to hydrogen peroxide to react at a temperature of 25 to 90 DEG C; then, reaction liquid is extracted or concentrated by pressure reduction, and refluxed to obtain oxysophocarpine. The technology has the advantages of simplicity, practicability and high product yield, and is suitable for industrialized production.

Description

The preparation technology of Sophocarpidin
Technical field
The present invention relates to alkaloidal preparation, especially the preparation technology of Sophocarpidin.
Background technology
Sophocarpidin is one of natural alkaloid, does not still have the production technique of the Sophocarpidin that is suitable for suitability for industrialized production at present.
Summary of the invention
The purpose of this invention is to provide a kind of preparation technology who is suitable for the Sophocarpidin of suitability for industrialized production, features simple and practical process.
For achieving the above object, the present invention is by the following technical solutions:
The preparation technology of Sophocarpidin, concrete processing step is as follows:
(1) sophocarpine is added in the hydrogen peroxide;
(2) be 25-90 ℃ of scope internal reaction in temperature;
(3) reaction finishes, and the unreacted sophocarpine of a kind of extraction with in ethers, hydro carbons, the benzene class material does not have till the sophocarpine in reaction solution substantially;
(4) reaction solution concentrating under reduced pressure, a kind of extraction in decompressed concentrate haloalkane, the Ester, extraction liquid concentrating under reduced pressure, get medicinal extract, use the alcohols material dissolution filter again, filtrate decompression concentrates, add letones in the concentrated solution and reflux, cool off, separate out crystallization, suction filtration gets Sophocarpidin.
The preparation technology of Sophocarpidin, concrete processing step also can be:
(1) sophocarpine is added in the hydrogen peroxide;
(2) be 25-90 ℃ of scope internal reaction in temperature;
(3) reaction finishes, and the unreacted sophocarpine of a kind of extraction with in ethers, hydro carbons, the benzene class material does not have till the sophocarpine in reaction solution substantially;
(4) reaction solution concentrating under reduced pressure, decompressed concentrate adds the siccative drying with a kind of extraction in haloalkane, the Ester in the extraction liquid, filter, and adds ether material in the filtrate, separates out crystallization, is Sophocarpidin.
The preparation technology of Sophocarpidin, concrete processing step can also be:
(1) sophocarpine is added in the hydrogen peroxide;
(2) be 25-90 ℃ of scope internal reaction in temperature;
(3) reaction finishes, and the unreacted sophocarpine of a kind of extraction with in ethers, hydro carbons, the benzene class material does not have till the sophocarpine in reaction solution substantially;
(4) reaction solution concentrating under reduced pressure adds the alcohols material dissolving, suction filtration, and filtrate decompression concentrates, and adds letones and refluxes, and suction filtration obtains white crystals, is Sophocarpidin.
The preparation technology of Sophocarpidin, concrete processing step can also be:
(1) sophocarpine is added in the hydrogen peroxide;
(2) be 25-90 ℃ of scope internal reaction in temperature;
(3) reaction finishes, and the unreacted sophocarpine of a kind of extraction with in ethers, hydro carbons, the benzene class material does not have till the sophocarpine in reaction solution substantially;
(4) reaction solution concentrating under reduced pressure, decompressed concentrate adds ether material with a kind of extraction in haloalkane, the Ester in the extraction liquid, separate out white solid, is Sophocarpidin.
The present invention has following effect:
(1) processing method is simple and practical.
(2) product purity height.Calculate with dry product, products obtained therefrom purity can reach more than 98%.
(3) product yield height.
(4) processing method is suitable for suitability for industrialized production.
Description of drawings
Fig. 1 is a process flow sheet of the present invention.
Embodiment
Embodiment 1:
The 20g sophocarpine is joined in the 15g hydrogen peroxide, after 14 hours,, in reaction solution, do not have till the sophocarpine substantially with the unreacted sophocarpine of extracted with diethyl ether in 70 ℃ of reactions.With the reaction solution concentrating under reduced pressure, the decompressed concentrate chloroform extraction, the extraction liquid concentrating under reduced pressure gets medicinal extract, filter with dissolve with ethanol, filtrate decompression concentrates again, and adds acetone in the concentrated solution and refluxes, cools off, separates out crystallization, suction filtration obtains crystallization 15.5g, is Sophocarpidin.
Embodiment 2:
The 20g sophocarpine is joined in the 15g hydrogen peroxide,, extract unreacted sophocarpine, in reaction solution, do not have till the sophocarpine substantially with hexanaphthene in 60 ℃ of stirring reactions 14 hours.Behind the reaction solution concentrating under reduced pressure, use chloroform extraction, add anhydrous sodium sulfate drying in the extraction liquid and filter, add anhydrous diethyl ether in the filtrate, separate out crystallization 13g, be Sophocarpidin.
Embodiment 3:
The 100g sophocarpine is joined in the 75g hydrogen peroxide,, extract unreacted sophocarpine, in reaction solution, do not have till the sophocarpine substantially with benzene 40 ℃ of following stirring reactions 18 hours.With the reaction solution concentrating under reduced pressure, chloroform extraction adds anhydrous diethyl ether slowly in the chloroform solution, separate out white solid 90g, is Sophocarpidin.
Embodiment 4:
The 100g sophocarpine is joined in the 75g hydrogen peroxide,, extract unreacted sophocarpine, in reaction solution, do not have till the sophocarpine substantially with toluene 25 ℃ of following stirring reactions 18 hours.With the reaction solution concentrating under reduced pressure, add dissolve with ethanol, suction filtration, filtrate decompression concentrates, and adds acetone and refluxes, and suction filtration obtains white crystals 90g, is Sophocarpidin.
Embodiment 5:
The 100g sophocarpine is joined in the 75g hydrogen peroxide,,, in reaction solution, do not have till the sophocarpine substantially with the unreacted sophocarpine of xylene extraction 25 ℃ of following stirring reactions 18 hours.With the reaction solution concentrating under reduced pressure, add dissolve with ethanol, suction filtration, filtrate decompression concentrates, and adds acetone and refluxes, and suction filtration obtains white crystals 90g, is Sophocarpidin.
Chloroform among the above embodiment 1,2,3 can use ethylene dichloride, monochloroethane, methylene dichloride or tetracol phenixin to substitute.Also can change chloroform into ethyl acetate.Ether, sherwood oil, benzene,toluene,xylene, cyclohexane give are that extract can mutual alternative in above embodiment 1,2,3,4.

Claims (12)

1. the preparation technology of Sophocarpidin, concrete processing step is as follows:
(1) sophocarpine is added in the hydrogen peroxide;
(2) be 25-90 ℃ of scope internal reaction in temperature;
(3) reaction finishes, and the unreacted sophocarpine of a kind of extraction with in ethers, hydro carbons, the benzene class material does not have till the sophocarpine in reaction solution substantially;
(4) reaction solution concentrating under reduced pressure, a kind of extraction in decompressed concentrate haloalkane, the Ester, extraction liquid concentrating under reduced pressure, get medicinal extract, use the alcohols material dissolution filter again, filtrate decompression concentrates, add letones in the concentrated solution and reflux, cool off, separate out crystallization, suction filtration gets Sophocarpidin.
2. the preparation technology of Sophocarpidin, concrete processing step is as follows:
(1) sophocarpine is added in the hydrogen peroxide;
(2) be 25-90 ℃ of scope internal reaction in temperature;
(3) reaction finishes, and the unreacted sophocarpine of a kind of extraction with in ethers, hydro carbons, the benzene class material does not have till the sophocarpine in reaction solution substantially;
(4) reaction solution concentrating under reduced pressure, decompressed concentrate adds the siccative drying with a kind of extraction in haloalkane, the Ester in the extraction liquid, filter, and adds ether material in the filtrate, separates out crystallization, is Sophocarpidin.
3. the preparation technology of Sophocarpidin, concrete processing step is as follows:
(1) sophocarpine is added in the hydrogen peroxide;
(2) be 25-90 ℃ of scope internal reaction in temperature;
(3) reaction finishes, and the unreacted sophocarpine of a kind of extraction with in ethers, hydro carbons, the benzene class material does not have till the sophocarpine in reaction solution substantially;
(4) reaction solution concentrating under reduced pressure adds the alcohols material dissolving, suction filtration, and filtrate decompression concentrates, and adds letones and refluxes, and suction filtration obtains white crystals, is Sophocarpidin.
4. the preparation technology of Sophocarpidin, concrete processing step is as follows:
(1) sophocarpine is added in the hydrogen peroxide;
(2) be 25-90 ℃ of scope internal reaction in temperature;
(3) reaction finishes, and the unreacted sophocarpine of a kind of extraction with in ethers, hydro carbons, the benzene class material does not have till the sophocarpine in reaction solution substantially;
(4) reaction solution concentrating under reduced pressure, decompressed concentrate adds ether material with a kind of extraction in haloalkane, the Ester in the extraction liquid, separate out white solid, is Sophocarpidin.
5. as the preparation technology of claim 1 or 2 or 4 described Sophocarpidins, haloalkane is chloroform, ethylene dichloride, monochloroethane, methylene dichloride or tetracol phenixin.
6. as the preparation technology of claim 1 or 2 or 3 or 4 described Sophocarpidins, benzene class material is a benzene,toluene,xylene.
7. as the preparation technology of claim 1 or 2 or 3 or 4 described Sophocarpidins, ether material is ether, sherwood oil.
8. as the preparation technology of claim 1 or 3 described Sophocarpidins, alcohols material is an ethanol.
9. as the preparation technology of claim 1 or 2 or 4 described Sophocarpidins, Ester is an ethyl acetate.
10. as the preparation technology of claim 1 or 3 described Sophocarpidins, letones is an acetone.
11. the preparation technology of Sophocarpidin as claimed in claim 2, siccative is anhydrous sodium sulphate, Calcium Chloride Powder Anhydrous.
12., it is characterized in that described hydro carbons is a hexanaphthene as the preparation technology of claim 1 or 2 or 3 or 4 described Sophocarpidins.
CNB001333518A 2000-11-18 2000-11-18 Preparation process of oxysophocarpine Expired - Fee Related CN1151154C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001333518A CN1151154C (en) 2000-11-18 2000-11-18 Preparation process of oxysophocarpine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001333518A CN1151154C (en) 2000-11-18 2000-11-18 Preparation process of oxysophocarpine

Publications (2)

Publication Number Publication Date
CN1354181A CN1354181A (en) 2002-06-19
CN1151154C true CN1151154C (en) 2004-05-26

Family

ID=4595670

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001333518A Expired - Fee Related CN1151154C (en) 2000-11-18 2000-11-18 Preparation process of oxysophocarpine

Country Status (1)

Country Link
CN (1) CN1151154C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100451019C (en) * 2006-08-31 2009-01-14 中国医学科学院放射医学研究所 Oxysophocarpine and its salt preparing method
CN102850352A (en) * 2012-07-26 2013-01-02 宁夏紫荆花制药有限公司 Preparation method high-purity high-yield oxysophocarpine

Also Published As

Publication number Publication date
CN1354181A (en) 2002-06-19

Similar Documents

Publication Publication Date Title
YU66003A (en) Method for separating hemicelluloses from a biomass containing hemicelluloses and biomass and hemicelluloses obtaining by said method
CN101659709B (en) Preparation method of fucosan
CN1966508A (en) Method for extracting cantharidin
EP3239165B1 (en) Composition containing nitrogen heterocyclic hexapeptide precursor and preparation method and application thereof
CN1151154C (en) Preparation process of oxysophocarpine
CN1151153C (en) Preparation process of oxysophoridine
CN101607926B (en) Method for removing sodium sulfate and sodium chloride from lauryl sodium sulfate
CN110283104B (en) Preparation method of arginine perindopril
CN1111533C (en) The preparation technology of Oxymatyine
CN103819572A (en) Extraction technology for production of polysaccharide from mulberry leaf
CN100395262C (en) Betulinol producing process
CN113307787B (en) Eutectic crystal of hesperetin and piperine and preparation method thereof
CN1631874A (en) Synthesis method of organic acid selenium
CN1106892C (en) Process for extracting pure tobacco oil, melanoid and nicotine and preparing composite fertilizer
CN102079883B (en) Novel process for extracting capsanthin and chilli extract by composite solvent
CN114516874A (en) Methotrexate new crystal form and preparation method thereof
CN114532535A (en) Preparation method of curcumin nano-liposome
CN1810797A (en) Prepn of flavone compound with guava leaf
CN1354179A (en) Preparation process of sophoridine
CN1392130A (en) Extracting and purifying method for hypericum perforatum component in plant
CN1390843A (en) process for extracting phosphatidecholine from powdered soybean phosphatide
US20220024969A1 (en) Method for extracting astragaloside iv from fresh radix astragali
WO2011004281A1 (en) A process for the preparation of amorphous form of rabeprazole sodium
CN1211349C (en) Process for preparing alpha-amidophenylketone with optical activity
CN117016853A (en) Preparation method and application of arecoline-beta-cyclodextrin inclusion compound

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040526

Termination date: 20121118